Dennis H. Oh, MD, PhD

Education

Professional Experience

• 1985-1993
  Trainee, Medical Scientist Training Program (MSTP), Stanford University School of Medicine
• 1987-1991
  Graduate student, Biophysics Program, Stanford University
• 1993-1994
  Internship, Department of Medicine, Brigham and Women's Hospital Clinical Fellow in Medicine, Harvard Medical School
• 1994-1998
  Residency, Department of Dermatology, Stanford University School of Medicine
• 1996-2000
  Postdoctoral fellow, Department of Dermatology and Biological Sciences, Stanford University
• 1998-2000
  Clinical Instructor, Department of Dermatology, Stanford University School of Medicine
• 7/00-10/00
  Assistant Adjunct Professor, Department of Dermatology, University of California, San Francisco
• 7/00-present
  Assistant Chief of Dermatology, San Francisco VA Medical Center
• 10/00-present
  Assistant Professor in Residence, Department of Dermatology, University of California, San Francisco
• 1/1/01-7/1/01
  Acting Chief of Dermatology, San Francisco VA Medical Center

Honors & Awards

• 1983
  American Heart Association Summer Student Research Internship, Lawrence Berkeley Laboratory, University of California at Berkeley
• 1983, 1984
  Korean Honor Scholarship, Republic of Korea
• 1985
  Graduation with Honors (Chemistry) and with Distinction, Stanford University
• 1985
  Firestone Medal for Excellence in Research, Stanford University
• 1985
  Phi Beta Kappa, Stanford University
• 1985
  Phi Lambda Upsilon (Chemistry), Stanford University
• 1985-1992
  National Research Service Award (Medical Scientist Training Program, Stanford University Medical School)
• 1996-1997
  Bank of America-Giannini Foundation Medical Research Fellow
• 1996-1997
  Cancer Research Foundation of America Fellowship
• 1997-2002
  Mentored Clinical Scientist Development Award (K08)
• 2001-2002
  Dermatology Foundation Research Grant
• 2001-2002
  U.C. San Francisco REAC Award
• 2002-2005
  VA Merit Review Entry Program Award

Selected Publications

1. Done N, Oh DH, Weinstock MA, Whited JD, Jackson GL, King HA, Peracca SB, Elwy AR, Prentice JC. VA Telederm study: protocol for a stepped-wedge cluster randomised trial to compare access to care for a mobile app versus a workstation-based store-and-forward teledermatology process. BMJ Open. 2018 Dec 14; 8(12):e022218.
   View on PubMed
2. Yim KM, Florek AG, Oh DH, McKoy K, Armstrong AW. Teledermatology in the United States: An Update in a Dynamic Era. Telemed J E Health. 2018 Sep; 24(9):691-697.
   View on PubMed
3. McKoy K, Antoniotti NM, Armstrong A, Bashshur R, Bernard J, Bernstein D, Burdick A, Edison K, Goldyne M, Kovarik C, Krupinski EA, Kvedar J, Larkey J, Lee-Keltner I, Lipoff JB, Oh DH, Pak H, Seraly MP, Siegel D, Tejasvi T, Whited J. Practice Guidelines for Teledermatology. Telemed J E Health. 2016 12; 22(12):981-990.
   View on PubMed
4. Dong TK, Ona K, Scandurra AE, Demetriou SK, Oh DH. Deficient Nucleotide Excision Repair in Squamous Cell Carcinoma Cells. Photochem Photobiol. 2016 09; 92(5):760-6.
   View on PubMed
5. Schulman JM, Oh DH, Sanborn JZ, Pincus L, McCalmont TH, Cho RJ. Multiple Hereditary Infundibulocystic Basal Cell Carcinoma Syndrome Associated With a Germline SUFU Mutation. JAMA Dermatol. 2016 Mar; 152(3):323-7.
   View on PubMed
6. Landow SM, Oh DH, Weinstock MA. Teledermatology Within the Veterans Health Administration, 2002-2014. Telemed J E Health. 2015 Oct; 21(10):769-73.
   View on PubMed
7. Zheng CL, Wang NJ, Chung J, Moslehi H, Sanborn JZ, Hur JS, Collisson EA, Vemula SS, Naujokas A, Chiotti KE, Cheng JB, Fassihi H, Blumberg AJ, Bailey CV, Fudem GM, Mihm FG, Cunningham BB, Neuhaus IM, Liao W, Oh DH, Cleaver JE, LeBoit PE, Costello JF, Lehmann AR, Gray JW, Spellman PT, Arron ST, Huh N, Purdom E, Cho RJ. Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomes. Cell Rep. 2014 Nov 20; 9(4):1228-34.
   View on PubMed
8. Tang JY, Fu T, Lau C, Oh DH, Bikle DD, Asgari MM. Vitamin D in cutaneous carcinogenesis: part I. J Am Acad Dermatol. 2012 Nov; 67(5):803.e1-12, quiz 815-6.
   View on PubMed
9. Tang JY, Fu T, Lau C, Oh DH, Bikle DD, Asgari MM. Vitamin D in cutaneous carcinogenesis: part II. J Am Acad Dermatol. 2012 Nov; 67(5):817.e1-11; quiz 827-8.
   View on PubMed
10. Bikle DD, Elalieh H, Welsh J, Oh D, Cleaver J, Teichert A. Protective role of vitamin D signaling in skin cancer formation. J Steroid Biochem Mol Biol. 2013 Jul; 136:271-9.
    View on PubMed
11. Hall BJ, Pincus LB, Yu SS, Oh DH, Wilson AR, McCalmont TH. Immunohistochemical prognostication of Merkel cell carcinoma: p63 expression but not polyomavirus status correlates with outcome. J Cutan Pathol. 2012 Oct; 39(10):911-7.
    View on PubMed
12. Demetriou SK, Ona-Vu K, Sullivan EM, Dong TK, Hsu SW, Oh DH. Defective DNA repair and cell cycle arrest in cells expressing Merkel cell polyomavirus T antigen. Int J Cancer. 2012 Oct 15; 131(8):1818-27.
    View on PubMed
13. Demetriou SK, Ona-Vu K, Teichert AE, Cleaver JE, Bikle DD, Oh DH. Vitamin D receptor mediates DNA repair and is UV inducible in intact epidermis but not in cultured keratinocytes. J Invest Dermatol. 2012 Aug; 132(8):2097-100.
    View on PubMed
14. Armstrong AW, Wu J, Kovarik CL, Goldyne ME, Oh DH, McKoy KC, Shippy AM, Pak HS. State of teledermatology programs in the United States. J Am Acad Dermatol. 2012 Nov; 67(5):939-44.
    View on PubMed
15. Huang ZM, Chinen M, Chang PJ, Xie T, Zhong L, Demetriou S, Patel MP, Scherzer R, Sviderskaya EV, Bennett DC, Millhauser GL, Oh DH, Cleaver JE, Wei ML. Targeting protein-trafficking pathways alters melanoma treatment sensitivity. Proc Natl Acad Sci U S A. 2012 Jan 10; 109(2):553-8.
    View on PubMed
16. Revet I, Feeney L, Bruguera S, Wilson W, Dong TK, Oh DH, Dankort D, Cleaver JE. Functional relevance of the histone gammaH2Ax in the response to DNA damaging agents. Proc Natl Acad Sci U S A. 2011 May 24; 108(21):8663-7.
    View on PubMed
17. Krishnan R, Oh DH. Structural determinants of photoreactivity of triplex forming oligonucleotides conjugated to psoralens. J Nucleic Acids. 2010 Jul 25; 2010.
    View on PubMed
18. de Feraudy S, Ridd K, Richards LM, Kwok PY, Revet I, Oh D, Feeney L, Cleaver JE. The DNA damage-binding protein XPC is a frequent target for inactivation in squamous cell carcinomas. Am J Pathol. 2010 Aug; 177(2):555-62.
    View on PubMed
19. Oh DH, Spivak G. Hereditary photodermatoses. Adv Exp Med Biol. 2010; 685:95-105.
    View on PubMed
20. Pincus LB, McCalmont TH, Neuhaus IM, Kasper R, Oh DH. Basal cell carcinomas arising within multiple trichoepitheliomas. J Cutan Pathol. 2008 Oct; 35 Suppl 1:59-64.
    View on PubMed

Go to UCSF Profiles, powered by CTSI